Human medicines European public assessment report (EPAR): Busulfan Fresenius Kabi, busulfan, Date of authorisation: 22/09/2014, Revision: 11, Status: Authorised

Minutes of the COMP meeting 13-15 May 2025

QRD guidance on the use of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised (DCP), subsequent recognition (SRP) and national procedures

QRD guidance on the use of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised (DCP), subsequent recognition (SRP) and national procedures

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Xydalba, dalbavancin, Date of authorisation: 19/02/2015, Revision: 21, Status: Authorised

Ibuprofen product-specific bioequivalence guidance

Dolutegravir product-specific bioequivalence guidance

Levothyroxine product-specific bioequivalence guidance